Panorama Capital

Panorama Capital Partners operates as a merchant bank, specializing in connecting Latin American companies with strategic global capital. The firm provides principal investments in private equity, growth capital, and private debt. It also offers comprehensive investment banking services, including capital raising, M&A advisory, and financial restructuring. These integrated offerings facilitate key transactions and strategic partnerships for regional businesses across Latin America.

Founding partners Stephanos Velissaropoulos and Juan Esteban Giraldo established the firm, leveraging their extensive financial market experience. Their core insight identified a significant opportunity to link Latin American growth with international capital and expertise. This vision led to the formation of a specialized merchant bank, crafted to navigate the region's distinct economic landscapes and address its diverse investment needs.

The firm serves Latin American businesses seeking financial backing and strategic guidance, alongside international investors targeting the region. Panorama Capital Partners aims to foster economic development and sustainable growth throughout Latin America. By providing tailored capital solutions and expert advisory, the firm acts as a crucial partner in client companies' financial evolution and expansion.

Panorama Capital is a venture capital firm founded in 2005 that invests primarily in life sciences and technology companies, focusing on supporting passionate entrepreneurs building market-leading companies. Their mission centers on fostering innovation and growth by providing not only capital but also hands-on, collaborative support leveraging their extensive operating and investing experience. The firm targets sectors including biotechnology, pharmaceuticals, healthcare, software, and mobile technologies, aiming to create lasting value and impact in these high-growth fields[2][3][4].

The firm’s investment philosophy emphasizes a deep commitment to the teams they back, valuing integrity, teamwork, and a shared passion for building great companies. Panorama Capital’s approach is highly collaborative, going beyond financial investment to actively support portfolio companies with strategic guidance. This model helps accelerate growth momentum for startups by combining capital with operational expertise, contributing positively to the broader startup ecosystem in life sciences and technology[2].

---

Panorama Capital was founded in 2005 in Campbell, California, by a team including Srinivas Akkaraju M.D., Ph.D., Christopher J. Albinson, Rodney A. Ferguson, J.D., Ph.D., Shahan D. Soghikian, and Damion E. Wicker, M.D. The founders brought together deep expertise in medicine, science, law, and investment, which shaped the firm’s focus on life sciences and technology. The idea emerged from their shared vision to back entrepreneurs who are passionate about innovation in these sectors. Over time, the firm has evolved to emphasize a hands-on, operator-first investment approach, supporting growth-stage companies with a strong thematic focus on healthcare and technology innovation[2][4].

---

Core Differentiators

• Unique Investment Model: Panorama Capital combines financial investment with active operational support, emphasizing a collaborative partnership with entrepreneurs rather than passive funding[2].
• Network Strength: The founding team’s diverse expertise in medicine, science, law, and investment provides a strong network and domain knowledge critical for life sciences and technology startups[2].
• Track Record: Since 2005, the firm has made over 80 investments, including notable exits and IPOs, demonstrating a successful history in identifying and scaling promising companies[2].
• Operating Support: The firm’s team brings extensive operating experience, offering strategic guidance and hands-on help to portfolio companies, which enhances their growth and market positioning[2].

---

Role in the Broader Tech Landscape

Panorama Capital rides the ongoing trend of increased innovation and investment in life sciences and technology, sectors driven by rapid advances in biotechnology, digital health, and software solutions. The timing is favorable due to growing global demand for healthcare innovation, personalized medicine, and technology-driven efficiencies. Market forces such as aging populations, rising healthcare costs, and digital transformation fuel the need for new solutions, positioning Panorama Capital to influence the ecosystem by enabling startups that address these critical challenges. Their active involvement helps bridge the gap between scientific innovation and commercial success, fostering a vibrant startup environment in these sectors[2][3].

---

Quick Take & Future Outlook

Looking ahead, Panorama Capital is likely to continue leveraging its deep sector expertise and collaborative investment model to back emerging leaders in life sciences and technology. Trends such as AI in healthcare, gene editing, and digital therapeutics will shape their investment focus. As these fields evolve, Panorama’s influence may grow by helping startups navigate complex regulatory landscapes and scale innovations globally. Their commitment to partnership and operational support positions them well to remain a key player in driving technological and scientific breakthroughs that transform healthcare and technology markets[2].

This forward-looking approach ties back to their founding mission of supporting passionate entrepreneurs building leading companies that make a lasting impact.